Integrated biomaterials approach that enhances adoptively transferred T cell therapy with cancer vaccine technology provides strong and long-lasting effects against solid tumors
Harvard and the University of Zurich partner to create a next-generation heart valve that accurately functions upon implantation and regenerates into long-lasting heart-like tissue
